ICH Efficacy Guidelines
The work carried out by ICH under the Efficacy heading is concerned with the design, conduct, safety and reporting of clinical trials. It also covers novel types of medicines derived from biotechnological processes and the use of pharmacogenetics / pharmacogenomics techniques to produce better targeted medicines.
ICH Efficacy Guidelines from E1 to E20
Click on the titles below for complete guidelines
E1 Clinical Safety for Drugs used in Long-Term Treatment
E7 Clinical Trials in Geriatric Population
E8 General Considerations for Clinical Trials
E9 Statistical Principles for Clinical Trials
E10 Choice of Control Group in Clinical Trials
E11 - E11A Clinical Trials in Pediatric Population
E12Clinical Evaluation by Therapeutic Category
E15 Definitions in Pharmacogenetics / Pharmacogenomics
E16 Qualification of Genomic Biomarkers
E17 Multi-Regional Clinical Trails
ICH Efficacy Guidelines from E1 to E20: